Singapore-based medtech company Us2.ai is expanding to Europe after receiving a CE mark for its automated decision support tool for echocardiography.
The Us2.v1 software is an automated clinical workflow solution that identifies and analyses two-dimensional and Doppler echo images for the diagnosis, prediction, and prognosis of heart disease and pulmonary hypertension. The company claims that its...
